136 related articles for article (PubMed ID: 29360362)
1. Taccalonolide Microtubule Stabilizers Generated Using Semisynthesis Define the Effects of Mono Acyloxy Moieties at C-7 or C-15 and Disubstitutions at C-7 and C-25.
Ola ARB; Risinger AL; Du L; Zammiello CL; Peng J; Cichewicz RH; Mooberry SL
J Nat Prod; 2018 Mar; 81(3):579-593. PubMed ID: 29360362
[TBL] [Abstract][Full Text] [Related]
2. Synthetic reactions with rare taccalonolides reveal the value of C-22,23 epoxidation for microtubule stabilizing potency.
Peng J; Risinger AL; Li J; Mooberry SL
J Med Chem; 2014 Jul; 57(14):6141-9. PubMed ID: 24959756
[TBL] [Abstract][Full Text] [Related]
3. Hydrolysis reactions of the taccalonolides reveal structure-activity relationships.
Li J; Peng J; Risinger AL; Mooberry SL
J Nat Prod; 2013 Jul; 76(7):1369-75. PubMed ID: 23855953
[TBL] [Abstract][Full Text] [Related]
4. Identification and biological activities of new taccalonolide microtubule stabilizers.
Peng J; Risinger AL; Fest GA; Jackson EM; Helms G; Polin LA; Mooberry SL
J Med Chem; 2011 Sep; 54(17):6117-24. PubMed ID: 21800839
[TBL] [Abstract][Full Text] [Related]
5. Taccalonolide Microtubule Stabilizers.
Yee SS; Du L; Risinger AL
Prog Chem Org Nat Prod; 2020; 112():183-206. PubMed ID: 33306174
[TBL] [Abstract][Full Text] [Related]
6. Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.
Li J; Risinger AL; Peng J; Chen Z; Hu L; Mooberry SL
J Am Chem Soc; 2011 Nov; 133(47):19064-7. PubMed ID: 22040100
[TBL] [Abstract][Full Text] [Related]
7. Taccalonolide microtubule stabilizers.
Li J; Risinger AL; Mooberry SL
Bioorg Med Chem; 2014 Sep; 22(18):5091-6. PubMed ID: 24491636
[TBL] [Abstract][Full Text] [Related]
8. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
Risinger AL; Li J; Du L; Benavides R; Robles AJ; Cichewicz RH; Kuhn JG; Mooberry SL
J Nat Prod; 2017 Feb; 80(2):409-414. PubMed ID: 28112516
[TBL] [Abstract][Full Text] [Related]
10. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
[TBL] [Abstract][Full Text] [Related]
11. Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
Du L; Risinger AL; Yee SS; Ola ARB; Zammiello CL; Cichewicz RH; Mooberry SL
J Nat Prod; 2019 Mar; 82(3):583-588. PubMed ID: 30799622
[TBL] [Abstract][Full Text] [Related]
12. Antitrypanosomal Activity of a Novel Taccalonolide from the Tubers of Tacca leontopetaloides.
Dike VT; Vihiior B; Bosha JA; Yin TM; Ebiloma GU; de Koning HP; Igoli JO; Gray AI
Phytochem Anal; 2016 May; 27(3-4):217-21. PubMed ID: 27313159
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic taccalonolides and withanolides from Tacca chantrieri.
Ni G; Yang HZ; Fu NJ; Zhang LL; Wang MC; Chen J; Zhang CL; Li Y; Chen XG; Chen RY; Yu DQ
Planta Med; 2015 Feb; 81(3):247-56. PubMed ID: 25679147
[TBL] [Abstract][Full Text] [Related]
14. Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach.
Du L; Yee SS; Ramachandran K; Risinger AL
Nat Commun; 2020 Jan; 11(1):654. PubMed ID: 32005831
[TBL] [Abstract][Full Text] [Related]
15. Taccachatrones A-G, Highly Oxidized Steroids from the Rhizomes of
He J; Ma R; Li ZH; Feng T; Liu JK
J Nat Prod; 2021 Aug; 84(8):2265-2271. PubMed ID: 34355562
[TBL] [Abstract][Full Text] [Related]
16. Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.
Risinger AL; Hastings SD; Du L
J Nat Prod; 2021 Jun; 84(6):1799-1805. PubMed ID: 34110822
[TBL] [Abstract][Full Text] [Related]
17. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.
Risinger AL; Jackson EM; Polin LA; Helms GL; LeBoeuf DA; Joe PA; Hopper-Borge E; Ludueña RF; Kruh GD; Mooberry SL
Cancer Res; 2008 Nov; 68(21):8881-8. PubMed ID: 18974132
[TBL] [Abstract][Full Text] [Related]
18. Taccalonolides: Novel microtubule stabilizers with clinical potential.
Risinger AL; Mooberry SL
Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
[TBL] [Abstract][Full Text] [Related]
19. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
Risinger AL; Mooberry SL
Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models.
Yee SS; Risinger AL
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
